Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 8/20 | 0.42 |
| ▸ | BRD4 | O60885 | 1/20 | 0.37 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.37 |
| ▸ | MCHR1 | Q99705 | 6/20 | 0.37 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | ACACA | Q13085 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12432861 | 1.00 | ACACB (0.42) | ACACBBRD4CREBBPMCHR1ADRB1 | |
| SCHEMBL1391850 | 0.85 | ACACB (0.52) | ACACBACACA | |
| SCHEMBL1391021 | 0.85 | ACACB (0.52) | ACACBACACA | |
| SCHEMBL1391157 | 0.85 | ACACB (0.52) | ACACBACACA | |
| SCHEMBL1391411 | 0.85 | ACACB (0.52) | ACACBACACA | |
| SCHEMBL7921645 | 0.78 | BRD4 (0.50) | ACACBBRD4CREBBPMCHR1 | |
| SCHEMBL1390761 | 0.75 | ACACA (0.55) | ACACBACACA | |
| SCHEMBL7921328 | 0.73 | ACACB (0.49) | ACACBACACA | |
| SCHEMBL12433361 | 0.73 | ACACB (0.49) | ACACBACACA | |
| SCHEMBL12433362 | 0.73 | ACACB (0.45) | ACACBMCHR1ACACA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010050445-A1 | BICYCLIC COMPOUND | 武田薬品工業株式会社 (JP) | 2010-05-06 | — | — | WO | disclosed |